Who We Are

ZemiTek, LLC is a Woman-Owned, SBA-certified 8(a) Small Disadvantaged Business (SDB) based in the Washington, DC metro area. We have a strong record delivering innovative and high-quality solutions. Since 2007, ZemiTek has provided technical assistance, project management, information technology (IT), knowledge management, monitoring and evaluation, training and learning development, and institutional support services.

Position Description

Global Solutions Ventures (GSV) – a joint-venture partnership between ZemiTek, LLC and Dexis Consulting Group – is implementing the Long-term Exceptional Technical Assistance Project (LEAP Global), a mechanism originally used by USAID to battle against infectious diseases such as malaria, HIV/AIDS, tuberculosis, neglected tropical diseases, and pandemic influenza. As of July 1, 2025, LEAP Global transitioned to the U.S. Department of State (DOS). This initiative aims to address the complex human resource challenges faced by national infectious disease programs in the USA-supported countries.

 

The intervention of this project is to hire and embed technical expert advisors and subject matter experts within government entities. By directly embedding the technical expertise within the national programs, LEAP provides long-term, sustainable lifesaving support to empower host governments to lead and manage key aspects of their infectious disease portfolios and improve coordination between the U.S. Government and the host country.

About the Position

Zimbabwe is implementing a decentralized, patient-centered response to drug-resistant tuberculosis (DR-TB) guided by the National TB Strategic Plan (NSP), WHO recommendations, and national PMDT guidelines. The program is expanding access to rapid molecular diagnostics, all-oral DR-TB regimens, and decentralized models of care while strengthening surveillance, supply chain systems, adherence support, and quality of care.

The Department of State will second a Senior DR-TB Advisor to provide specialized technical assistance to the NTP. The Advisor will support policy development, program implementation, partner coordination, and scale-up of innovations to improve DR-TB detection, treatment outcomes, and prevention. The Advisor will support the NTP in carrying out life-saving humanitarian assistance (LHA) service delivery in full alignment with the new Presidential Executive Order (EO) directives. 

 

The Senior DR-TB Advisor will provide strategic and operational technical leadership to strengthen prevention, diagnosis, treatment, and care of drug-resistant TB in Zimbabwe. The Advisor will support decentralized PMDT service delivery, scale-up of WHO-recommended diagnostics and regimens, integration of DR-TB and HIV services, implementation of TB grants, and use of data for program improvement.

Responsibilities

DR-TB Policy, Strategy, and Decentralized Service Delivery

• Support development and implementation of national strategies and operational plans for high-quality, decentralized PMDT services.
• Facilitate periodic review and updating of national PMDT guidelines in line with WHO recommendations and emerging evidence.
• Support implementation and strengthening of decentralized and community-based models of DR-TB care, including task-sharing and differentiated service delivery.
• Support DR-TB conciliar at national, provincial, and facility levels to guide complex case management.

Diagnosis, Surveillance, and DRS

• Support sustained access to WHO-recommended rapid molecular diagnostics, in collaboration with the Directorate of Laboratory Services.
• Provide technical support for Drug Resistance Surveillance (DRS), including planning, implementation, data analysis, and use of findings to inform policy and programming.
• Support timely diagnosis and linkage to care for DR-TB cases.

Treatment, Regimens, and DR-TB Prevention

• Provide technical support for implementation and scale-up of WHO-recommended all-oral DR-TB regimens, including BPAL(M) regimens.
• Support implementation of DR-TB prevention interventions, including use of fluoroquinolone-based preventive therapy (e.g., levofloxacin) for eligible contacts, in line with national policy.
• Support development and implementation of strategies to enhance adherence, retention, and treatment completion for DR-TB patients.
• Support routine DR-TB cohort reviews at national and sub-national levels to assess performance and guide corrective actions.
• Support roll out of the DRTB tracker and other digital innovations to enhance TB DRTB care.

Training, Capacity Building, and Mentorship

• Support review, updating, and dissemination of standardized national P